RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 125 filers reported holding RA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,793,000 | -45.4% | 303,258 | -55.7% | 0.01% | -50.0% |
| Q4 2018 | $12,449,000 | +22.6% | 683,995 | +21.8% | 0.01% | +233.3% |
| Q3 2018 | $10,158,000 | +1316.7% | 561,522 | +679.4% | 0.00% | – |
| Q2 2018 | $717,000 | +197.5% | 72,041 | +58.5% | 0.00% | – |
| Q1 2018 | $241,000 | -3.2% | 45,441 | +55.1% | 0.00% | – |
| Q4 2017 | $249,000 | -45.5% | 29,294 | -6.3% | 0.00% | – |
| Q3 2017 | $457,000 | -22.0% | 31,271 | 0.0% | 0.00% | – |
| Q2 2017 | $586,000 | +250.9% | 31,271 | +299.0% | 0.00% | – |
| Q1 2017 | $167,000 | +178.3% | 7,837 | +97.0% | 0.00% | – |
| Q4 2016 | $60,000 | – | 3,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |